Replies to post #26781 on Abattis Bioceuticals Corp. (ATTBF)

[ebota12]

It could, but it doesn't. Abattis specifically chose to exit this market.

High bacteria and contaminates could mean BioCube demands, but alas....they are not focused here either.

Best case scenario is a CSL Dealer License, but again...if there was a chance of this happening I don't think multiple CEO's would resign right before their free shares were actually worth something.

[guay]

Northern Vine Labs™ operations under the CSL will include:
1. Analytical Services
2. Research and Development Services
3. Extraction to Support Analysis and R&D
In future, NV Labs™ anticipates the opportunity to amend its license to include:
4. Extraction service for sale of extracted ingredients
5. Importation/Exportation

Security inspections are complete and the license is pending. Northern Vine Labs™ product certification and quality assurances programs incorporate global best practices and procedures for application in the Canadian market.

Source: http://www.abattis.com/northern-vine